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1171-30 A Meta-Analysie of Risks Versus Benefit of Oral 
Antlcoagulation on Top of Aspirin Following Unstable 
Angina or Myocardial Infarction 
Freek W. Verheuot. Marc A. Brouwer, Robed F. van Es, Michael D. Ezekowitz, Louise 
Fiore, Valentin Fustar, University Medical Center Nijmegen, Nijmegen, The Netherlands, 
Thoraxcenter, Rotterdam, The Netherlands. 
Background: Since the introduction of lower doses of aspirin and better standardized 
control of oral anticoagulation (OAC) using INR, combined aspirin/OAC therapy has been 
evaluated against aspirin in large post MI trials. The risks of such a strategy have been a 
matter of concern, but have not been systematically evaluated against the benefit. 
Methods: In the 5 randomized tdals comparing OAC/aspirin with aspirin alone following 
unstable angina or MI (ATACS, CARS, CHAMP, APRICOT-2 and ASPECT-2 including 
15,044 patients) death, reinfarction and stroke were recorded. Stroke classification 
(ischemic or hemorrhagic) was available in 155 stroke cases out of 6,027 patients evalu- 
ated. 
Results: See table. 
Conolusions: Coumadin on top of aspirin is beneficial with an acceptable bleeding risk: 
3 death/reinfarctions are prevented at the cost of 1 major bleeding. The reduction of 
ischemic stroke is even larger with no excess hemorraghic strokes. 
Results: aspirin + aspidn RR p 
coumadin (n=6,522) 
(n=8,522) 
deafh/reinfarction 15.3 % 17.6 % 0.87 (0.81-0.93) 0.002 
major bleeding 2.4 % 1.7 % 1.43 (1.14-1.80) 0.003 
stroke 2.3 % 2.8 % 0.83 (0.60-1.14) 0.28 
• ischemic ol .8 % .2.4 % 0.75 (0.63-1.06) 0.13 
• hemorrhagic ,,0.5 % °0.5 % 1.07 (0.54.2.13) 0.99 
1171-31 Pred ic t ing  Surv iva l  From the Coronary Arteriogram: An 
Experience-Based Statistical Index of  Coronary  Ar tery  
Disease Severity 
David F. Kono. Linda K. Shaw, Frank E. Harrell, Jr., Lawrence H. Muhibaier, Kerry L. Lee, 
Robert M. Califf, Robert H, Jones, Duke Clinical Research Institute, Durham, North 
Carolina. 
Background: For patients (pts) with coronary artery disease (CAD), accurate assess- 
ment of survival hinges on the coronary arteriogram. Classification by 0-, 1-, 2-, and 3- 
vessel disease (0123-vd) introduces error by grouping pts with heterogeneous prog- 
noses together. A CAD severity index was developed to overcome this fundamental limi- 
tation. 
Methods: We constructed a hierarchy of anatomic categories based upon the presence 
of mild (50-74%), significant (75-95%), and severe (>95%) lesions in each of the three 
coronary vessels. Left main (LM) and proximal left anterior descending coronary lesions 
were characterized separately. A Cox proportional hazards modal fitted the relative 
weights of the categories using survival data from 29,082 pts catheterized at Duke Medi- 
cal Center between 1986 - 1999 and treated without revasculadzation. Scaling each of 
the regression coefficients by the maximum coefficient (for severe LM disease) created a 
CAD severity index ranging from 0 to 100. 
Results: The Duke CAD index separates pts into 14 classes. Cox model chi-square (X 2) 
was 2447 with 13 degrees of freedom for all-cause mortality. When applied as a linear 
score in pts with CAD, the Cox model X 2 was 6403 for the CAD index compared to 6024 
for the 0123-vd method. The CAD index consistently performed better than the 0123-vd 
method in adjusted models. 
Conclusion: This experience-based index facilitates prognostication, and creates a new 
benchmark for rational evaluation of percutaneous and surgical treatments for CAD. 
• = t00 "1 
80 
4g 
~ ~, . . . . . . . .  
A B C D E F G H I J K L M N 
n~ CAD Severity Class (A = None, N = Severe left main) 
1171-32 P lasma Leve ls  o f  Oxidized Low Density Lipoprotein 
(Ox-LDL)  Relate to Coronary Events After Angioplasty 
in Patients With Unstable Angina Pectoris 
Haiime Yamashita, Shoichi Ehara, Takahiko Naruko, Kazuo Haze, Minoru Yoshiyama, 
Toshihiko Matsuo, Kazuhide Takeuchi, Junichi Yoshikawa, Makiko Ueda, Department of 
Internal Medicine and Cardiology, Osaka City University Graduate School of Medicine, 
Osaka, Japan. 
Background: We have recently reported that plasma ox-LDL levels on admission relate 
directly to the severity of coronary syndromes, using a novel anti-ox-LDL monoclonal 
antibody and anti-apolipoprotein B antibody (Ehara et ah Circulation 2001; 103: 1955- 
1960). Moreover, immunohistochemical investigations of atherectomy specimens dem- 
onstrated that the surface area containing ox-LDL-positive mecrophage was significantly 
higher in unstable angina pectoris (UAP) patients than in stable angina pectoris (SAP) 
patients. In this study, we investigated whether the plasma levels of ox-LDL at follow-up 
relate to follow-up angiographic outcomes in patients with UAP and SAP, undergoing 
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percutanecus coronary intervention. Methods and Results: Plasma ox-LDL levels were 
measured in patients with 48 UAP and 37 SAP at the follow-up period, Coronary events 
rates (restenosis and new lesion) was 19% in SAP and 31% in UAP. In SAP patients, 
there was no difference in plasma ox-LDL levels between groups with and without coro- 
nary events. In UAP patients, however, plasma ox-LDL levels in the group with coronary 
events were significantly higher than in the group without coronary events (with coronary 
events: 1.23¢0.78, without coronary events: 0.74¢0.49 ng/5 pg LDL protein, mean±SD). 
Conclusion: Our results suggest that elevated plasma levels of ox-LDL relate to the pro- 
gression of human coronary atherosclerotic lesions or the neointima formation in the 
patients with UAP. 
1171-47 Mycoplasma Pneumoniae High  IgA Titer but Not IgG 
Predicts Increased Hazard of Death or Myocardial 
Infarction Among Patients With Angiographically 
Defined Coronary  Ar tery  Disease 
Tobin H. Lira, Joseph B. Muhlestain, John F. Cadquist, Bella Ohana, Mark Lipson, 
Benjamin D. Home, Jeffrey L. Anderson, LDS Hospital, Salt Lake City, Utah, Savyon 
Diagnostics, Ashdod, Israel. 
Background: Intracallular infectious agents, including Chlamydia pneumonias and a 
variety of viruses, are linked to the development and/or progression of coronary artery 
disease (CAD). From a cross-sectional study of patients (pts) undergoing angiography, 
we reported that seropositivity to Mycoplasma pneumoniae (Mpn), another intracellular 
bacterium, also predicts the diagnosis of CAD. To further evaluate this association, we 
tested whether seropositivity to Mpn also predicts death or MI among CAD pts. 
Methods: Blood samples were collected from 1,517 consenting pts with severe, anglo- 
graphically-defined CAD (>_1 lesion of 270% stanosis). ELtSA antibody levels (Savyon 
Diagnostics) were measured for Mpn IgG and IgA, and serologic status was assigned 
according to product specifications (negative, positive, or high-positive). Pts were fol- 
lowed to death (all-cause and cardiac), MI, or censor (mean=2.4±1.6 years, max=5.8 
years) and data were analyzed by Cox proportional hazards regression. 
Reaults: Average age was 65±11 years and 77% were male. Serologic findings for Mpn 
IgG were 61% negative, 36% positive, and 3.5% high-positive, and for IgA were 45%, 
42%, and 13%, respectively. For IgG titars, events occurred in 21%, 20%, and 19% of 
negative, positive, and high-positive pts, respectively (all p=NS). For IgA, event rates 
were significantly higher for high positive vs. negative (26% vs. 16%, adjusted: p=0.04, 
hazard ratio [HR]=1.5, 95%C1=[1.1,2.1]), but not for simple positive vs. negative (20% vs. 
16%, p=0.40, HR=I.2). Similar results were found for death due to cardiac causes (for 
high-positive vs. negative, adjusted HR=I.7, p=0.02). Other predictors of increased 
death/MI hazard were age, C-reactive protein, diabetes, renal failure, and number of dis- 
eased coronaries. 
Conclusions: High Mycoplasma pneumoniae IgA serologic titar, which is suggestive of 
recent infection, independently and significantly predicts increased hazard of death or MI 
events in pts with severe, angiographically-defined CAD. This finding provides further 
evidence Of an association between Mpn and CAD and adds to the number of intracellu- 
lar infectious agents associated with coronary events. 
1171-48 Sudden Death and Diabetes Mellitus: The Role of  
Parental  Antecedents  in the Paris Prospective Study I 
Xavier X. Jouven, Beverley Balkau, Ludivine Andujar, Michel Desnos, Claude Guerot, 
Pierre Ducimetiere, Inserm U258, Villejuif, France, HEGP, Pads, France. 
Objective: Diabetes mellitus and a parental history of sudden death are risk factors par- 
ticularly associated with sudden death in the population. Since both diabetes mellitus and 
sudden death may be inherited, we assessed their relationship among two generations 
of men in a long-term cohort study. 
Methods : 7746 subjects underwent ECG and physical examination conducted by a phy- 
sician in standardized conditions, provided blood samples for laboratory tests, and 
answered questionnaires administered by trained interviewers. Diabetes melUtus was 
coded at inclusion if diabetes was declared by the subjects or fasting plasma glucose 
was >= 7 mmol/l. The vital status was obtained from specific inquiries until retirement and 
then by death certificates. Men with known ischemic heart disease were further excluded 
from analysis which was conducted on the 7079 remaining subjects. 
Results : 496 men declared a paternal history of sudden death and 213 a paternal history 
of diabetes. The relative risk of sudden death was 1.9 in diabetic compared with nondia- 
betic fathers (p=0.001). Sudden death represented 20% of the total mortality, and myo- 
cardial infarction 10%. 
After an average follow-up period of 23 years of the population, there were 2083 deaths, 
among which 603 cardiovascular deaths including 118 sudden deaths and 192 fatal myo- 
cardial infarctions. Among the 395 diabetic subjects, 169 were deceased, 48 from cardio- 
vascular disease, 15 from sudden death (9%) and 12 from myocardial infarction(5%). 
The relative risk of sudden death was 2.5 in diabetic subjects compared with nondiabetic 
subjects (p=0.0007). 
Conclusion : Diabetes mellitus is associated across generations with a particular high 
risk of sudden death. 
